GlassScriptPhysician profile
Jordan Evans
NPI 1629537576
$2,672.14
in general payments reported to CMS, 2019-2025
19 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.67 · 2023: $299 · 2024: $1,129 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,410.93 |
| Education | $247.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $376.61 | 2023-2025 | |
| Dermavant Sciences, INC. | $328.34 | 2023-2024 | Vtama |
| Ucb, INC. | $257.13 | 2022-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $246.21 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $199.80 | 2023-2025 | Sotyktu |
| Pfizer INC. | $196.69 | 2024-2025 | |
| Janssen Biotech, INC. | $186.96 | 2025 | Tremfya |
| Incyte Corporation | $161.92 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $129.15 | 2024-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $120.56 | 2024-2025 | Libtayo, Dupixent |
| Sun Pharmaceutical Industries INC. | $117.13 | 2024-2025 | |
| Organon LLC | $112.30 | 2024-2025 | Vtama, Hadlima |
| Amgen INC. | $65.30 | 2025 | Otezla, Otezla |
| Fresenius Kabi USA, LLC | $55.90 | 2024 | Idacio |
| Lilly USA, LLC | $46.94 | 2024-2025 | Taltz, Ebglyss |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $22.26 | 2024 | |
| Arcutis Biotherapeutics, INC. | $19.12 | 2025 | Zoryve |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.05 | 2023 | Siliq |
| Kerecis Limited | $12.77 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.